EIF5A2 was shown to associate with metastasis, developmental stages, histological types and poor patient survival in gall bladder cancer [34], oral squamous cell carcinoma [35], prostate cancer [36], cervical cancer [37], and hepatocellular carcinoma [38]. Here, EIF5A2 is linked to oral cavity squamous cell carcinoma.